rs11575926

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005535.3(IL12RB1):​c.467G>A​(p.Arg156His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.159 in 1,597,014 control chromosomes in the GnomAD database, including 22,380 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R156C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.12 ( 1420 hom., cov: 31)
Exomes 𝑓: 0.16 ( 20960 hom. )

Consequence

IL12RB1
NM_005535.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.41

Publications

35 publications found
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IL12RB1 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002072394).
BP6
Variant 19-18077598-C-T is Benign according to our data. Variant chr19-18077598-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 328598.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB1NM_005535.3 linkc.467G>A p.Arg156His missense_variant Exon 5 of 17 ENST00000593993.7 NP_005526.1 P42701-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB1ENST00000593993.7 linkc.467G>A p.Arg156His missense_variant Exon 5 of 17 1 NM_005535.3 ENSP00000472165.2 P42701-1
IL12RB1ENST00000600835.6 linkc.467G>A p.Arg156His missense_variant Exon 6 of 18 1 ENSP00000470788.1 P42701-1
IL12RB1ENST00000322153.11 linkc.467G>A p.Arg156His missense_variant Exon 5 of 10 1 ENSP00000314425.5 P42701-3

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18197
AN:
152004
Hom.:
1419
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0294
Gnomad AMI
AF:
0.0934
Gnomad AMR
AF:
0.0919
Gnomad ASJ
AF:
0.190
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.0796
Gnomad FIN
AF:
0.198
Gnomad MID
AF:
0.102
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.123
GnomAD2 exomes
AF:
0.127
AC:
31791
AN:
250760
AF XY:
0.130
show subpopulations
Gnomad AFR exome
AF:
0.0283
Gnomad AMR exome
AF:
0.0677
Gnomad ASJ exome
AF:
0.192
Gnomad EAS exome
AF:
0.000761
Gnomad FIN exome
AF:
0.188
Gnomad NFE exome
AF:
0.174
Gnomad OTH exome
AF:
0.137
GnomAD4 exome
AF:
0.163
AC:
234981
AN:
1444892
Hom.:
20960
Cov.:
27
AF XY:
0.161
AC XY:
115887
AN XY:
719732
show subpopulations
African (AFR)
AF:
0.0236
AC:
783
AN:
33158
American (AMR)
AF:
0.0695
AC:
3103
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.191
AC:
4969
AN:
26032
East Asian (EAS)
AF:
0.000530
AC:
21
AN:
39618
South Asian (SAS)
AF:
0.0819
AC:
7031
AN:
85896
European-Finnish (FIN)
AF:
0.184
AC:
9821
AN:
53378
Middle Eastern (MID)
AF:
0.144
AC:
827
AN:
5736
European-Non Finnish (NFE)
AF:
0.182
AC:
199374
AN:
1096588
Other (OTH)
AF:
0.151
AC:
9052
AN:
59812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8817
17634
26450
35267
44084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6776
13552
20328
27104
33880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18201
AN:
152122
Hom.:
1420
Cov.:
31
AF XY:
0.119
AC XY:
8830
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0293
AC:
1216
AN:
41532
American (AMR)
AF:
0.0918
AC:
1402
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
660
AN:
3472
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5176
South Asian (SAS)
AF:
0.0810
AC:
391
AN:
4830
European-Finnish (FIN)
AF:
0.198
AC:
2088
AN:
10570
Middle Eastern (MID)
AF:
0.113
AC:
33
AN:
292
European-Non Finnish (NFE)
AF:
0.178
AC:
12064
AN:
67958
Other (OTH)
AF:
0.122
AC:
257
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
799
1598
2397
3196
3995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
1166
Bravo
AF:
0.108
TwinsUK
AF:
0.179
AC:
665
ALSPAC
AF:
0.189
AC:
729
ESP6500AA
AF:
0.0359
AC:
158
ESP6500EA
AF:
0.174
AC:
1494
ExAC
AF:
0.126
AC:
15244
Asia WGS
AF:
0.0350
AC:
123
AN:
3478
EpiCase
AF:
0.174
EpiControl
AF:
0.167

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Immunodeficiency 27A Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 09, 2015
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.16
DANN
Benign
0.88
DEOGEN2
Benign
0.21
T;T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0080
N
LIST_S2
Benign
0.71
.;T;T
MetaRNN
Benign
0.0021
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
L;L;L
PhyloP100
-1.4
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-2.1
.;.;N
REVEL
Benign
0.13
Sift4G
Benign
0.093
T;T;T
Polyphen
0.014
B;B;B
Vest4
0.039
MPC
0.11
ClinPred
0.0016
T
GERP RS
-7.8
Varity_R
0.021
gMVP
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11575926; hg19: chr19-18188408; COSMIC: COSV59097132; COSMIC: COSV59097132; API